Recruitment of diverse populations and subjects living in Medically Underserved Areas and
Populations (MUA/P's) into clinical trials is a considerable challenge. Likewise …

Pharmacogenetics is a subset of personalized medicine that applies knowledge about
genetic variation in gene–drug pairs to help guide optimal dosing. There is a lack of data …

Implementation strategies for pharmacogenetic testing have been largely limited to major
academic medical centers and large health systems, threatening to exacerbate healthcare …

Hospital systems increasingly utilize pharmacogenomic testing to inform clinical prescribing.
Successful implementation efforts have been modeled at many academic centers. In …

Introduction: Pharmacogenetic testing may hold promise in addressing health disparities, as
medically underserved patients appear to be prescribed medications with pharmacogenetic …

Precision Medicine, the practice of targeting prevention and therapies according to an
individual's lifestyle, environment or genetics, holds promise to improve population health …

Disparities exist in enrollment in clinical trials and biorepositories among adults with low
socioeconomic status, racial and ethnic minority groups and individuals who live in rural …

Pharmacogenetic research offers the potential to improve the safety and efficacy of drug
prescribing. Assuring that the benefits of this research reach indigenous and other medically …

Introduction The implementation of pharmacogenetic analysis within clinical trials faces
methodological, ethical, and regulatory challenges, as well as tackling the difficulty in …

Importance Socioeconomically disadvantaged patients, such as persons with low income
and those with low educational attainment, are less likely to participate in clinical trials than …